IP Verse

Stolmar & Partner patent opposition analysis

Law FirmOpposition Filing Analysis

The comprehensive analysis of Stolmar & Partner opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Stay updated with the latest patent oppositions filed by Stolmar & Partner

Patent Number	Title	Applicant	Opposition Date	Opposition Company
EP4321157	New Use Of A Combination Of An Angiotensin Receptor Blocker (Arb) With A Neutral Endopeptidase Inhibitor (Nepi)	NOVARTIS	Jul 18, 2025	EGIS
EP3626270	New Use	NOVARTIS	Jul 8, 2024	EGIS
EP3294283	Sacubitril-Valsartan Dosage Regimen For Treating Heart Failure	NOVARTIS	Oct 9, 2023	EGIS
EP2959894	S1P Receptor Modulators For Treating Multiple Sclerosis	NOVARTIS	Jul 11, 2023	EGIS
EP2234617	Dosing Regimen Associated With Long Acting Injectable Paliperidone Esters	JANSSEN PHARMACEUTICA	Dec 31, 2021	EGIS
EP2582754	Tacky Finish And Textile Materials And Articles Treated Therewith	MILLIKEN	Sep 2, 2021	KORDSA TEKNIK TEKSTIL
EP2617807	Culture Substrate	ASAHI GLASS	Jul 21, 2021	STOLMAR & PARTNER PATENTANWALTE PARTG MBB
EP3307798	Alignment Compounds	TRANSITIONS OPTICAL	May 4, 2021	STOLMAR & PARTNER PATENTANWALTE PARTG MBB
EP2933321	Grease Composition Ameliorating Low-Temperature Fretting	KYODO YUSHI	Nov 13, 2019	KLUBER LUBRICATION MUNCHEN
EP3110721	Cup For A Coffee Capsule	SACMI COOPERATIVA MECCANICI IMOLA SOCIETA COOPERATIVA	Oct 2, 2019	STOLMAR & PARTNER PATENTANWALTE PARTG MBB

Top companies who are the clients of Stolmar & Partner

Company	Total
EGIS	6
STOLMAR & PARTNER PATENTANWALTE PARTG MBB	3
BUHLMANN LABORATORIES	1
KLUBER LUBRICATION MUNCHEN	1
KORDSA TEKNIK TEKSTIL	1
STOLMAR	1